Industry
Pharmaceuticals
Topic
Employment and Board Changes
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Board and Executive Moves in Pharmaceuticals
... past three seasons. The Friars were 14-18 overall and 4-11 in the Trinity League during his tenure. This past season they finished 6-5 overall and ...
... and booking of explored reserves are in progress ZABAIKALSKY REGION, RUSSIA Novoshirokinskoye (Novo) Ore mining in Q4 2017 totalled 222,488 tonnes, a 13% increase over ...
... applicable Uruguayan law. SECTION 5 ICC LABS FINANCIALS FY2016 Annual Report: ICC International Cannabis reports EPS of -53.0c 5.1 Annual Report: Key Parameters ICC International ...
... CANADIAN DAILY STOCK REPORT Acerus Pharmaceuticals Corporation (TSX:ASP), Canada's 4th largest Drug manufacturers company by market cap, has ...
... CANADIAN WEEKLY STOCK REPORT Valeant Pharmaceuticals International, Inc. (TSX:VRX), Canada's largest Drug Manufacturers company by market cap, has sunk ...
... Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi Appoints Dominique Carouge Executive Vice President Head ...
... Pfizer, and has also served with then GlaxoWellcome in Canada. Release > GlaxoSmithKline named Filippo Lanzi as regional head of Asia Pacific. He came to ...
... UPM Pharmaceuticals, a Contract Development and Manufacturing Organization (CDMO) focused on solid oral ...
... the deal. AGS plans to list on the NYSE as "AGS." [ts_bullet_primary] ARMO Biosciences , a Redwood City, Calif.-based immunotherapy developer, said it plans to ...
... Sosei Group Corporation ("Sosei" or the "Company") (TOKYO: 4565), the world leader in GPCR ...
... years as Vice President of U.S. Sales with DePuy Synthes, a Johnson & Johnson (J&J) company. During his tenure at J&J, Tim managed the fastest ...
... Board Chair and Senior Vice President, Clinical Projects & Quantitative Sciences at GlaxoSmithKline. "We could not be more pleased that Chris and Pam are bringing ...
... Tuebingen, Germany and Houston, Texas - Immatics, a leading company in the field of cancer immunotherapy, today announced the ...
... blood cells, while in the second, they bind to liver cells. RELATED: Celgene splashes out $300M on Delinia autoimmune biotech buy In addition to his ...
... Inositec has named former Roche and Novartis staffer Frits van Alphen, M.D., as ...
... and another about how it can do better. The success story involves Merck KGaA penning another deal with Cancer Research UK, which continues to act ...
... clinical trials. Prior to FORMA, he held roles of increasing responsibility at Novartis AG, most recently as senior vice president and global head of development ...
... Immunovaccine Names Joseph Sullivan, Experienced Global Pharmaceutical and Vaccine Executive, as Senior Vice President, Business Development ...
... its direction to blockchain technology. The Company is changing its name to Millennium Blockchain (www.mblockchain.io) and has brought on key executives to partner with current ...
... Lannett Company, Inc. (NYSE: LCI) today announced that Timothy C. Crew, the company's recently appointed ...
... a giant British pharmaceutical company has taken notice. NeuroMetrix announced Wednesday that GlaxoSmithKline has agreed to pay the company $5 million to own and market ...
... Inositec , a pioneer in the development of life-saving small molecule drugs based ...
... Corporate Wire Date: 17 January 2018 15:30 EST ORIGINAL ANNOUNCEMENT [Text] CanniMed Therapeutics Inc. (TSX:CMED) ("CanniMed" or the "Company") is pleased to announce the launch ...
Want to see the full history on Board and Executive Moves in Pharmaceuticals? Upgrade to RelSci Pro now!
Start My Free Trial